Cited by 46HIV Research and TreatmentHIV/AIDS drug development and treatmentVirus-based gene therapy research

Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation

Nakamura, Tahei, Masuda, Takao, Goto, Toshiyuki, Sano, Kouichi, Nakai, Masuyo, Harada, Shinji·1997·Biochemical and Biophysical Research Communications

Abstract

The integrase (IN) encoded by human immunodeficiency virus type-1 (HIV-1) is required for integration of the viral DNA into a host cell chromosome. The function of the highly conserved HHCC motif in the HIV-1 IN amino-terminal zinc finger-like domain is still unknown. In this study, we examined the effect of mutations in the HHCC motif on viral infectivity, adsorption to and entry into target cells, and morphology in the context of a full-length form of an HIV-1 molecular clone. A complete lack of infectivity and de novo synthesized viral DNA of the HHCC mutants were demonstrated in both cell-free and co-culture infection systems using MT-2 or HeLa-CD4-LTR-beta-gal as target cells. The levels of viral adsorption to and entry into the target cells were determined by measuring the cell-associated p24 level in target MT-2 cells shortly after infection. We detected comparable cell-associated p24 levels of MT-2 cells after infection with wild-type and the mutant viruses. Taken together, these results suggest that the replication of HIV-1 carrying point mutations in the HHCC motif was blocked at the step after adsorption/ entry and prior to the initiation of reverse transcription, presumably at the uncoating step. Furthermore, electron microscopy revealed that the observed complete lack of viral infectivity caused by introducing an amino acid substitution into the HHCC motif is not always accompanied by apparent abnormal morphology or maturation of virus particles.

Integrity signals

Registry

Crossref · 10.1006/bbrc.1997.7541

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In HIV-1, IN has nonenzymatic/noncatalytic roles affecting different steps in the viral life cycle beyond integration.

    “Interestingly, in the case of HIV-1, IN has also been shown to have nonenzymatic/noncatalytic roles, affecting different steps in the viral life cycle beyond integration.”
  • Mutations in IN can affect uncoating, reverse transcription, nuclear import of viral DNA, and protein processing during viral assembly.

    “Further studies have revealed that mutations in IN can affect uncoating, reverse transcription, nuclear import of viral DNA, and protein processing during viral assembly (Engelman et al. 1995, Masuda et al. 1995, Nakamura et al. 1997, Wu et al. 1999, Tsurutani et al. 2000, Ikeda et al. 2004, Briones et al. 2010).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nakamura, T., Masuda, T., Goto, T., Sano, K., Nakai, M., & Harada, S.
Affiliations
Kumamoto University (JP)
Corresponding author
Masuda, Takao
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
1997-10
Volume
239
Issue
3
Pages
715-722
ISSN
0006-291X (ISSN-L)
OpenAlex
W2087660104
Cited by
46
References
1
Citations by year
2025: 1 · 2022: 2 · 2021: 1 · 2020: 3 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 2
FWCI
0.20
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HIV-1 integrase, integrase mutations, viral infectivity, viral entry, viral attachment, viral uncoating, virus maturation, virus morphology, reverse transcription initiation, MT-2 cells
MeSH terms
Adsorption, Animals, HeLa Cells, Humans, Virion, Virus Replication, HIV-1, HIV Infections, Zinc Fingers, Point Mutation, Protein Structure, Tertiary, HIV Integrase, COS Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review